Physician profile
Jennifer Simone
NPI 1558490581
$16,111.42
in general payments reported to CMS, 2019-2025
25 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $4,645 · 2021: $647 · 2022: $578 · 2023: $9,383 · 2024: $224 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $1,478 · Travel and Lodging: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $1,478.22 |
| Travel and Lodging | $287.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,120.39 | 2020-2023 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $1,060.81 | 2020-2025 | Acessa Provu System, Aptima, Novasure |
| Abbvie INC. | $648.33 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Therapeuticsmd, INC. | $397.02 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.81 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $86.56 | 2019-2021 | |
| Gynesonics, INC. | $80.03 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $72.66 | 2019-2020 | |
| Astellas Pharma US INC | $66.30 | 2023-2024 | Veozah |
| Organon LLC | $64.93 | 2021-2025 | Nexplanon |
| Aspira Women'S Health INC | $58.04 | 2023-2024 | Ova1 |
| Minerva Surgical, INC | $57.55 | 2019-2023 | |
| Pfizer INC. | $37.24 | 2022-2024 | |
| Exeltis, USA INC. | $36.92 | 2019-2021 | |
| Allergan, INC. | $35.90 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $33.84 | 2022 | |
| Lupin INC. | $29.17 | 2019-2021 | |
| Applied Medical Resources Corporation | $24.01 | 2023 | |
| Mallinckrodt Enterprises LLC | $21.10 | 2019 | |
| Mayne Pharma Commercial LLC | $19.72 | 2021 | |
| Boston Scientific Corporation | $17.51 | 2019 | |
| Mylan Pharmaceuticals INC. | $16.42 | 2020 | |
| Si-Bone, INC. | $13.83 | 2025 | |
| Monaghan Medical Corporation | $13.71 | 2023 | Aerochamber |
| Avion Pharmaceuticals | $12.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Simone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.